Remove Licensing Remove Presentation Remove Public Health Remove World Health
article thumbnail

Reclaiming Global Public Health

Bill of Health

The answer to one of the most important public health questions of our time — who gets access to vaccines? — Private decisions did not match public health need. Monopoly control presents profound questions for public health governance. Zain Rizvi is a research director at Public Citizen.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Legally speaking, patent pledges are comparable to the open source software licenses that underlie much of the world’s technology infrastructure and the Creative Commons licenses that make billions of online images, videos and other content freely available (both discussed here ). Tesla and Toyota) to software (e.g,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. A concerted and collaborative effort is essential to address this threat to global health, economies, and security effectively.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

The EC presented a first draft for public comment to the revision of Annex 1 in 2017. More than 6,000 comments led, quite unusually, to a second draft for renewed public comment in 2020. Long awaited, the final version of Annex 1 was published on 25 August 2022.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

In addition, it contains essential recommendations to avoid complications and protect public health. This extends the earlier 31 December 2023 deadline, which requires medicines for Great Britain (GB) to be presented in GB compliant packaging. about how they use sunscreen products.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada.

article thumbnail

COVID-19: As Omicron Variant Spreads, Let’s Not Repeat Rookie Mistakes

HIT Consultant

The variant, named Omicron (the fifteenth letter in the Greek alphabet), was first reported to the World Health Organisation (WHO) by South Africa on November 24th. Unlike its name would suggest, Omicron is the seventh COVID-19 variant of concern—but a pandemic-fatigued global public could be forgiven for thinking it’s the twentieth.